AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
AtaiBeckley announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. As Chief Financial Officer at AtaiBeckley, he will lead the Company's financial strategy, capital markets activities, and overall financial operations. Anne Johnson, who has served as Chief Financial Officer since 2024, will transition to the role of Chief Accounting Officer upon the effective date of Faerm's appointment. Faerm most recently served as Chief Financial Officer at Viracta Therapeutics
